Hidaka M - Search Results

1

[Beneficial effect of salazosulfapyridine (SASP) in a patient with secondary renal amyloidosis].

Hidaka M, Ohsawa I, Endo M, Fujita T, Ohi H, Kanmatsuse K, Kusumi Y, Yamaguchi Y. Hidaka M, et al. Nihon Jinzo Gakkai Shi. 1998 Sep;40(7):555-9. Nihon Jinzo Gakkai Shi. 1998. PMID: 9805922 Japanese.

2

[Three cases of pregnancy in primary glomerulonephritis with successful outcomes in spite of severe histological findings].

Hidaka M, Ohi H, Ohsawa I, Endo M, Fujita T, Kanmatsuse K. Hidaka M, et al. Nihon Jinzo Gakkai Shi. 1999 Jun;41(4):454-9. Nihon Jinzo Gakkai Shi. 1999. PMID: 10441996 Japanese.

3

Worsening fluid retention in a patient with hereditary angioedema and end-stage renal disease.

Ohsawa I, Satomura A, Fuke Y, Hidaka M, Endo M, Fujita T, Ohi H. Ohsawa I, et al. Among authors: hidaka m. Intern Med. 2004 Aug;43(8):708-12. doi: 10.2169/internalmedicine.43.708. Intern Med. 2004. PMID: 15468971 Free article.

4

Inhibitory effect of free sialic acid on complement activation and its significance in hypocomplementemic glomerulonephritis.

Fujita T, Satomura A, Hidaka M, Ohsawa I, Endo M, Ohi H. Fujita T, et al. Among authors: hidaka m. J Clin Lab Anal. 1999;13(4):173-9. doi: 10.1002/(SICI)1098-2825(1999)13:4<173::AID-JCLA6>3.0.CO;2-U. J Clin Lab Anal. 1999. PMID: 10414597 Free PMC article.

5

Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy.

Fujita T, Satomura A, Hidaka M, Ohsawa I, Endo M, Ohi H. Fujita T, et al. Among authors: hidaka m. Calcif Tissue Int. 2000 Mar;66(3):195-9. doi: 10.1007/s002230010039. Calcif Tissue Int. 2000. PMID: 10666494 Clinical Trial.

6

A case of renal involvement in persistent immune activation caused by chlamydial salpingitis.

Ohsawa I, Ohi H, Endo M, Fujita T, Hidaka M, Satomura A, Yamaguchi Y. Ohsawa I, et al. Among authors: hidaka m. Virchows Arch. 2001 Mar;438(3):306-11. doi: 10.1007/s004280000314. Virchows Arch. 2001. PMID: 11315629

7

PGl2 analogue mitigates the progression rate of renal dysfunction improving renal blood flow without glomerular hyperfiltration in patients with chronic renal insufficiency.

Fujita T, Fuke Y, Satomura A, Hidaka M, Ohsawa I, Endo M, Komatsu K, Ohi H. Fujita T, et al. Among authors: hidaka m. Prostaglandins Leukot Essent Fatty Acids. 2001 Oct;65(4):223-7. doi: 10.1054/plef.2001.0315. Prostaglandins Leukot Essent Fatty Acids. 2001. PMID: 11728176 Clinical Trial.

8

Glomerular deposition and urinary excretion of complement factor H in idiopathic membranous nephropathy.

Endo M, Fuke Y, Tamano M, Hidaka M, Ohsawa I, Fujita T, Ohi H. Endo M, et al. Among authors: hidaka m. Nephron Clin Pract. 2004;97(4):c147-53. doi: 10.1159/000079174. Nephron Clin Pract. 2004. PMID: 15331938

9

Regulation of in situ complement activation via the lectin pathway in patients with IgA nephropathy.

Endo M, Ohi H, Satomura A, Hidaka M, Ohsawa I, Fujita T, Kanmatsuse K, Matsushita M, Fujita T. Endo M, et al. Among authors: hidaka m. Clin Nephrol. 2001 Mar;55(3):185-91. Clin Nephrol. 2001. PMID: 11316237

10

Cryoprecipitate of patients with cryoglobulinemic glomerulonephritis contains molecules of the lectin complement pathway.

Ohsawa I, Ohi H, Tamano M, Endo M, Fujita T, Satomura A, Hidaka M, Fuke Y, Matsushita M, Fujita T. Ohsawa I, et al. Among authors: hidaka m. Clin Immunol. 2001 Oct;101(1):59-66. doi: 10.1006/clim.2001.5098. Clin Immunol. 2001. PMID: 11580227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

749 results

Search Page

Filters